IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+11.95%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(+36%)
Cap. Flow
+$7.51M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
132
New
23
Increased
7
Reduced
12
Closed
26
Top Buys
| 1 |
argenx
ARGX
|
$26.5M |
| 2 |
SPDR S&P Homebuilders ETF
XHB
|
$19.1M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
$12.9M |
| 4 |
Sarepta Therapeutics
SRPT
|
$12.8M |
| 5 |
Annexon
ANNX
|
$12M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$45.7M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$12.4M |
| 3 |
Akero Therapeutics
AKRO
|
$10.1M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$8.89M |
| 5 |
Vaxcyte
PCVX
|
$7.26M |
Sector Composition
| 1 | Healthcare | 92.55% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $26.5M | 2.48% | +70,000 | New | +$26.5M |
|
2
Crinetics Pharmaceuticals
CRNX
$2.92B
| $24.2M | 2.27% | 680,370 -112,550 | -14% | -$4M |
|
3
Soleno Therapeutics
SLNO
$3.6B
| $23.8M | 2.22% | 590,243 +53,523 | +10% | +$2.15M |
|
|
4
SPDR S&P Homebuilders ETF
XHB
$1.92B
| $19.1M | 1.79% | +200,000 | New | +$19.1M |
|
5
BridgeBio Pharma
BBIO
$9.89B
| $19.1M | 1.79% | 473,126 | – | – |
|
6
Nuvalent
NUVL
$5.52B
| $19M | 1.78% | 258,142 -19,892 | -7% | -$1.46M |
|
|
SLRN
7
DELISTED
ACELYRIN
SLRN
| $14.9M | 1.39% | 1,991,005 -927,421 | -32% | -$6.92M |
|
|
8
Amylyx Pharmaceuticals
AMLX
$836M
| $12.9M | 1.21% | +877,500 | New | +$12.9M |
|
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $12.8M | 1.2% | +132,640 | New | +$12.8M |
|
|
10
Annexon
ANNX
$226M
| $12M | 1.13% | +2,650,000 | New | +$12M |
|
11
Disc Medicine
IRON
$2.07B
| $11.3M | 1.05% | 194,982 +52,216 | +37% | +$3.02M |
|
12
Tarsus Pharmaceuticals
TARS
$2.47B
| $10.5M | 0.98% | 518,519 | – | – |
|
13
Immunovant
IMVT
$2.56B
| $9.83M | 0.92% | 233,394 -64,400 | -22% | -$2.71M |
|
|
ALPN
14
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $9.29M | 0.87% | +487,248 | New | +$9.29M |
|
15
EyePoint Pharmaceuticals
EYPT
$797M
| $8.51M | 0.8% | +368,130 | New | +$8.51M |
|
16
Catalyst Pharmaceutical
CPRX
$2.52B
| $8.5M | 0.8% | 505,862 | – | – |
|
|
MRNS
17
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.11M | 0.76% | 746,069 | – | – |
|
18
Protagonist Therapeutics
PTGX
$3.67B
| $7.31M | 0.68% | +319,000 | New | +$7.31M |
|
|
19
Rocket Pharmaceuticals
RCKT
$354M
| $7.18M | 0.67% | 239,726 -415,000 | -63% | -$12.4M |
|
|
ICVX
20
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $6.93M | 0.65% | +440,000 | New | +$6.93M |
|
21
Lyra Therapeutics
LYRA
$11.5M
| $6.57M | 0.62% | 1,254,384 | – | – |
|
|
LBPH
22
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $5.91M | 0.55% | 979,462 +465,361 | +91% | +$2.81M |
|
23
Cabaletta Bio
CABA
$133M
| $4.92M | 0.46% | +216,620 | New | +$4.92M |
|
|
FUSN
24
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $4.81M | 0.45% | +500,000 | New | +$4.81M |
|
|
25
Praxis Precision Medicines
PRAX
$958M
| $4.46M | 0.42% | 200,000 -2,050,000 | -91% | -$45.7M |
|